2019
DOI: 10.1016/j.chemosphere.2019.01.182
|View full text |Cite
|
Sign up to set email alerts
|

Genotoxic and mutagenic assessment of spinosad using bioassays with Tradescantia pallida and Drosophila melanogaster

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 47 publications
0
4
0
Order By: Relevance
“…This is despite evidence that the toxicity of spinosad to honeybees may be similar to that of imidacloprid (Challa et al, 2019;Christen et al, 2019). The mechanism of action and resistance to spinosad is being studied using whole genome sequencing of different D. melanogaster and D. suzukii strains that show different resistance levels, the polymorphisms associated with resistance are then edited into the genome using CRISPR mediated mutagenesis, with mutations in the α6 nAChR subunit being found to mediate resistance to spinosad (Zimmer et al, 2016;Mishra et al, 2018;Mendonca et al, 2019). This makes understanding the full suite of sub-lethal effects and the modes of action of neonicotinoids vital, as well as developing models for rapid identification of such effects caused by current and future pesticides.…”
Section: The Eu Ban Of Neonicotinoids and Their Continued Global Usementioning
confidence: 99%
See 1 more Smart Citation
“…This is despite evidence that the toxicity of spinosad to honeybees may be similar to that of imidacloprid (Challa et al, 2019;Christen et al, 2019). The mechanism of action and resistance to spinosad is being studied using whole genome sequencing of different D. melanogaster and D. suzukii strains that show different resistance levels, the polymorphisms associated with resistance are then edited into the genome using CRISPR mediated mutagenesis, with mutations in the α6 nAChR subunit being found to mediate resistance to spinosad (Zimmer et al, 2016;Mishra et al, 2018;Mendonca et al, 2019). This makes understanding the full suite of sub-lethal effects and the modes of action of neonicotinoids vital, as well as developing models for rapid identification of such effects caused by current and future pesticides.…”
Section: The Eu Ban Of Neonicotinoids and Their Continued Global Usementioning
confidence: 99%
“…Whilst we know that only some nAChR subtypes are susceptible to neonicotinoids (Moffat et al, 2016), the composition of these subtypes has not been fully determined. However, exploration of neonicotinoid resistance using D. melanogaster as a model has identified some nAChR subunits which appear to be involved in susceptibility, such as Dα1, Dβ1, and Dβ2 (Perry et al, 2012;Homem et al, 2020), in contrast α6 nAChR subunit is important for spinosad's mode of action and resistance (Zimmer et al, 2016;Mishra et al, 2018;Mendonca et al, 2019).…”
Section: Genomementioning
confidence: 99%
“…It is structurally and chemically related to spinosyn produced by Saccharopolyspora spinosa [ 2 , 3 ]. Butenyl-spinosyn has excellent activity against various insects, such as Lepidoptera, Diptera, and Coleoptera, but has little or no effect on a broad range of nontarget insects and mammals, making it one of the most promising biological pesticides [ 4 , 5 ]. At present, the butenyl-spinosyn biosynthetic gene cluster ( bus cluster) and its biosynthetic pathway have been elaborated [ 2 , 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Structurally, the spinosyn family is composed of a central macrolide ring system (aglycon) with rhamnose and forosamine sugars at the 9- and 17-positions, respectively. , Spinosad is a widely used insecticide featuring high efficacy against Diptera, Thysanoptera, and especially Lepidopteran pests with low toxicity to nontarget organisms . However, shortcomings of conventional spinosad formulations such as easy photolysis or hydrolysis , result in their repeated and excessive application, which thereby leads to increased environmental risks , as well as relatively high costs. Recently, sustained/controlled-release formulations of spinosad have shown great potential in reducing side effects of conventional formulations based on the advantages of small effective dose, prolonged release time, , and particularly specific environmental responsiveness. …”
Section: Introductionmentioning
confidence: 99%